In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents
β Scribed by N.D. Sonawane; Chatchai Muanprasat; Ray Nagatani Jr.; Yuanlin Song; A.S. Verkman
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 218 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The primary purpose of this study is to investigate the degree to which we can improve the prediction of rodent carcinogenicity (CA) by combining results from an in vitro and two in vivo genotoxicity tests. We used the Ames Salmonella assay (SAL) for the in vitro test and the micronucleus assay (MNC
## Abstract The inhibitor of p38 mitogenβactivated protein kinase (MAPK) is of interest in the nonoperative treatment of periprosthetic osteolysis due to wear particles. Previous studies demonstrated that an oral p38 MAPK inhibitor did not suppress bone formation when given during the initial phase